A Method for Interdicting the Development of Severe Jaundice in Newborns by Inhibiting the Production of Bilirubin
- 1 January 2004
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 113 (1) , 119-123
- https://doi.org/10.1542/peds.113.1.119
Abstract
This statement is intended to inform pediatricians and other health care professionals, parents, superintendents, and school board members about nutritional concerns regarding soft drink consumption in schools. Potential health problems associated with high intake of sweetened drinks are 1) overweight or obesity attributable to additional calories in the diet; 2) displacement of milk consumption, resulting in calcium deficiency with an attendant risk of osteoporosis and fractures; and 3) dental caries and potential enamel erosion. Contracts with school districts for exclusive soft drink rights encourage consumption directly and indirectly. School officials and parents need to become well informed about the health implications of vended drinks in school before making a decision about student access to them. A clearly defined, district-wide policy that restricts the sale of soft drinks will safeguard against health problems as a result of overconsumption.Keywords
This publication has 19 references indexed in Scilit:
- Development of Heme Oxygenase Inhibitors for the Prevention of Severe Jaundice in InfantsPublished by Springer Nature ,2002
- Sn-Mesoporphyrin Interdiction of Severe Hyperbilirubinemia in Jehovah’s Witness Newborns as an Alternative to Exchange TransfusionPediatrics, 2001
- Zinc porphyrins: Potent inhibitors of hematopoieses in animal and human bone marrowProceedings of the National Academy of Sciences, 1997
- Pharmacokinetics of tin-mesoporphyrin in man and the effects of tin-chelated porphyrins on hyperexcretion of heme pathway precursors in patients with acute inducible porphyriaHepatology, 1989
- Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjectsHepatology, 1988
- Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolismArchives of Biochemistry and Biophysics, 1987
- Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver.Proceedings of the National Academy of Sciences, 1987
- Proof that Sn-protoporphyrin inhibits the enzymatic catabolism of heme in vivo. Suppression of 14CO generation from radiolabeled endogenous and exogenous heme sources.The Journal of Experimental Medicine, 1987
- The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin.Proceedings of the National Academy of Sciences, 1985
- Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation.Proceedings of the National Academy of Sciences, 1981